Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

NCT01888302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Complication

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine Hydrochloride
OTHER: Quality-of-Life Assessment
DRUG: Sirolimus

Sponsor

Mayo Clinic

Collaborators

[object Object]